Novartis AG said profit will rise this year as new medicines help offset the competition it expects from copycats of its best-selling medicine.Core operating profit will likely grow by a high single- ...
Source LinkNovartis AG said profit will rise this year as new medicines help offset the competition it expects from copycats of its best-selling medicine.Core operating profit will likely grow by a high single- ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.